- Work +1 212 318 3000
- Work 212 318 3108
Life sciences and healthcare
United States: Antitrust
Civil litigation/class actions
Within: Civil litigation/class actions
Norton Rose Fulbright US LLP’s traditional strengths are in energy, healthcare, technology, entertainment (particularly disputes involving movie distribution) and transport, with clients including the likes of Phillips 66, Shell, Baylor Health Care System, and ABX Logistics. Anne Rodgers, who is based in Houston alongside practice head Layne Kruse and Darryl Anderson, was particularly active, and recent highlights for her include handling the appeal, for client American Alloy Steel, of a jury trial verdict that found that steel service centers and mills participated in a group boycott to shut down a competing steel service center. In Washington DC, Neely Agin made partner, while in New York, the group added Robin Adelstein, a life sciences expert who joined from an in-house position at Novartis.
United States: Dispute resolution
Within: International litigation
Norton Rose Fulbright US LLP has recently bolstered its international litigation practice with several additions to its already talented team. Paul Keller, who focuses on patent and trade secret litigation, joined the firm’s New York office from Allen & Overy LLP in July 2015. Robin Adelstein, former counsel to the generics division of Novartis, arrived in the New York office in the same month. David Navetta and Boris Segalis, cybersecurity experts based in Denver and New York respectively, came on board in November 2014. These four joined Houston-based Gerard Pecht, the global head of dispute resolution and litigation, and Louis Strubeck, who splits his time between New York and Dallas. In a recent highlight, Bill Leone represented a former managing director in JPMorgan’s chief investment office in various proceedings brought by regulatory enforcement agencies in the US and elsewhere, including the DOJ, the SEC and the UK’s Financial Conduct Authority. The firm services global corporations such as AT&T, General Electric and Shell.
United States: Industry focus
Healthcare: life sciences
Within: Healthcare: life sciences
Norton Rose Fulbright US LLP’s team advises a range of pharmaceutical, medical device and biotechnology companies, as well as investors in the life sciences sector. The practice has a solid IP litigation practice and a strong government investigations group. In a recent highlight, Michael Koon and Carol Poindexter acted on a putative nationwide class action on behalf of third-party payors alleging RICO and common law violations from the operation of GlaxoSmithKline co-pay assistance programs. Washington DC-based Frederick Robinson co-heads the global life sciences and healthcare practice, which enhanced its transactional capabilities with the arrival of Andres Liivak from Kaye Scholer LLP in May 2015 and, in July 2015, the arrival of former Sandoz general counsel Robin Adelstein. Liivak advised Novartis on a license, development and commercialization deal with XOMA in which Novartis acquired the global rights to XOMA’s anti-transforming growth factor-beta antibody program. Yvonne Puig ‘communicates with clients effectively’ and is able to ‘effectively manage large, complex litigation’. All individuals are based in Austin unless otherwise stated.
Healthcare: service providers
Within: Healthcare: service providers
Norton Rose Fulbright US LLP handles big-ticket transactions and notable regulatory and litigation mandates. It has a huge presence in Texas, but represents healthcare providers nationwide, and recently advised the University of Arizona Health Network on its $1bn merger with Banner Health. Austin-based senior litigator Yvonne Puig is ‘excellent’, delivers ‘practical advice’ and has ‘poise under pressure’. Austin-based Jerry Bell, Dallas’ Lisa Genecov, and James Wiehl in St Louis are recommended for transactions. Washington DC’s Rick Robinson is noted for government investigations and white-collar criminal cases. The New York presence has grown through a sequence of lateral hires, including Robin Adelstein, former North American general counsel of Sandoz.